Tenax Therapeutics Inc. – Filings and Transcripts

NASDAQ: TENX
Share price (3/13/26): $13.84
Market cap (3/13/26): $238 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024

Prospectuses and Registrations Filter

Prospectus supplement

Shelf registration

Registration of securities for employees

Prospectus supplement

Registration of securities for employees

Ownership Filter

Giordano Christopher Thomas

Logos Global Management LP

Dellora Investments LP

Venrock Healthcare Capital Partners III, L.P.

Rtw Investments, LP

News Filter

Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

Change in Directors, Officers or Compensation, Financial Statements or Exhibits

Announces Result of Prespecifed Blinded Sample Size Assessment

Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Announces European Patent Office Intention to Grant Patent Covering Use of Levosimendan in PH-HFpEF

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Definitive proxy

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness